Noxogen Therapeutics is a developer of a novel proprietary formulation for the sustained release of nitric oxide. The formulation, intended to be applied with the use of a medical device, can release nitric oxide locally over various periods of time. It’s development targets treatment of a wide range of medical disorders due to its powerful anti-inflammatory, antimicrobial, and vasoregulatory effects.

The Company operates a business model based on developing high-potential life sciences assets until preclinical proof of concept in targeted indications and then enters into partnerships for further development and/or licensing.